Testing the expression of RAC3 in serum and urine of high-risk individuals with bladder disease symptoms or with a family history of the disease, and performing more detailed examinations if abnormal results are found, could help in the early detection of bladder cancer patients. This evidence concerns the gene RAC3 and urinary bladder carcinoma.